In addition, a chimpanzee adenovirus–vectored COVID-19 vaccine, iNCOVACC, was approved in India and found to stimulate mucosal IgA (12.3%) responses and CMI responses as assessed by S-specific IFN secreting T cells (24). The gene discussed is IFNA1; the disease is COVID-19.